FDA approves Novartis' gene therapy for rare muscle disorder-December 2024-www.financetom.com

FDA approves Novartis' gene therapy for rare muscle disorder

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

FDA approves Novartis' gene therapy for rare muscle disorder

Nov 24, 2025 2:41 PM

Nov 24 (Reuters) - U.S. Food and Drug Administration has

approved Novartis' gene therapy for a type of rare

muscle disorder, the drugmaker said on Monday.

(Reporting by Sriparna Roy in Bengaluru)

Previous page： Govt to grandfather LPG subsidy regime for BPCL consumers for 3-5 years Next page： Schneider Electric puts luminous power biz on the block

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Govt to grandfather LPG subsidy regime for BPCL consumers for 3-5 years

Nov 25, 2020

CNBC-TV18 learned from sources that the government will grandfather the LPG subsidy regime post-BPCL strategic sale and the oil ministry will seek the Cabinet approval for this shortly.

Schneider Electric puts luminous power biz on the block

Nov 25, 2020

A large transaction in the consumer electric business has hit the deal street. According to sources, global major Schneider Electric has put its luminous power business on the block.

Uber drivers can now cash out any day of the week

Nov 25, 2020

”To help drivers in these challenging times, we’ve rolled-out an On-Demand cash-out feature which allows them the flexibility to cash out at any day of the week, instead of waiting for their weekly cash outs.”

Travel portals warn mandatory RT-PCR tests will hurt air travel

Nov 25, 2020

Air travel continued to increase in November but mandatory RT-PCR tests may put a damper going forward.